1255 — TATA Health International Holdings Cashflow Statement
0.000.00%
Consumer CyclicalsHighly SpeculativeMicro Cap
Annual cashflow statement for TATA Health International Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | — | — |
Source: | ARS | ARS | ARS | ||
Standards: | HKAS | HKAS | — | — | — |
Status: | Final | Final | Final | fx Preliminary | fx Preliminary |
Net Income/Starting Line | -173 | -69.1 | 4.1 | — | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 101 | 4.29 | -54.7 | — | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 47.8 | 46.2 | 51.6 | — | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 0.255 | -4.9 | 13 | — | — |
Capital Expenditures | -3.08 | -1.08 | -0.886 | — | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -15.9 | -38.7 | 8.81 | — | — |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -19 | -39.8 | 7.93 | — | — |
Financing Cash Flow Items | 43.5 | 9.83 | 8.75 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.012 | 43.2 | -14 | — | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -18.6 | -1.47 | 6.91 | — | — |